Although an EEG is one of the main tools for diagnosing epilepsy, a negative or normal EEG test does not necessarily rule out epilepsy. encephalopathy (brain dysfunction that may have a variety of causes)Īn EEG cannot diagnose mental illnesses.Your doctor may recommend an EEG to diagnose or monitor conditions including: What conditions can an EEG test help diagnose? The test is safe and doesn’t hurt, as it is merely recording the brain’s electrical activity. If something is unusual about the brain’s electrical activity, it will show up in the EEG recording. This electrical activity is shown on a computer as ‘brain waves’, which are interpreted by a specialist doctor. Rapid-EEG alters the treatment course for patients with suspected seizures and will result in cost savings per patient.Įlectroencephalography cost–benefit analysis decision tree model medical device neurology neuroscience non-convulsive status epilepticus seizure status epilepticus.An EEG records the electrical signals sent between brain cells. Results were obtained from the analysis of existing data and not a prospective outcome trial. Sixty-four percent of variance in total costs was attributable to LOS for persons incorrectly diagnosed with seizures. Cost-savings were demonstrated in 75% of replications. Using PSA, Rapid-EEG saving was $5,633 per use case (95% PI: $($4,649 to $6,617), as it led to diminished hospital LOS by 1.1 days (95% PI: 0.9-1.4 days) and reduced ICU LOS by 0.5 days (95% PI: 0.4-0.6 days). 7.4 days) and ICU LOS by 0.4 days (1.5 vs. All costs were indexed to 2019 US$.Įach use case of Rapid-EEG saved $3,971 to $17,290 as it led to reduction in the hospital LOS by 1.2 days (6.1 vs. We calculated reference case estimates from mean values, while uncertainty was assessed using 95% prediction intervals (PI) generated by probabilistic sensitivity analysis (PSA) and ANCOVA sum of squares.

Diagnostic parameters were informed by a multicenter clinical trial (DECIDE, NCT03534258), while LOS and cost parameters were from public US inpatient data, published literature, and Center for Medicare and Medicaid Services fee schedules.

We built a two-armed decision-analytic cost-benefit model comparing Rapid-EEG with clinical suspicion alone for NCSE.

The current study aimed to examine the effect of a new EEG system (Ceribell Rapid Response EEG, Rapid-EEG) on hospital costs by enabling easy access to EEG and expedited seizure diagnosis and treatment. Either may prolong hospital length of stay (LOS). When access to EEG is limited, physicians may empirically treat, risking unnecessary sedation and intubation, or not treat, increasing risk of refractory seizures. Potentially life-threatening diagnosis of non-convulsive status epilepticus (NCSE) can only be confirmed with electroencephalography (EEG).

Eeg cost